This video examines phase II results of a single-arm trial that tested checkpoint inhibition plus the IDO–pathway inhibitor indoximod in patients with melanoma.
Yousef N. Zakharia, MD
Advertisement
Articles by Yousef N. Zakharia, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Medicare Cuts Coverage in Image-Guided Superficial Radiotherapy, Lawsuit Filed
2
What Does the Future Hold for Bispecific Antibodies in Multiple Myeloma?
3
Rusfertide May Become Part of Polycythemia Vera Armamentarium
4
Redefining mHSPC Sequencing: Exploring Impact of PSMAddition
5